Back to mobile site

UPDATE: JPMorgan Starts Cellebrite (CLBT) at Overweight

February 24, 2022 4:06 AM EST Send to a Friend
(Updated - February 24, 2022 4:38 AM EST)

JPMorgan analyst Sterling Auty initiates coverage on Cellebrite (NASDAQ: CLBT) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login